T

Titan Pharmaceuticals
D

TTNP

3.43000
USD
0.14
(4.26%)
مغلق
حجم التداول
242
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
3,135,823
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABBV
    ABBV
    1.540
    (0.86%)
    179.990 USD
    A
    AMRN
    0.01170
    (2.63%)
    0.45670 USD
    BMY
    BMY
    0.180
    (0.31%)
    57.750 USD
    GILD
    GILD
    0.480
    (0.51%)
    93.850 USD
    JNJ
    JNJ
    0.560
    (0.39%)
    145.790 USD
    LLY
    LLY
    -3.40
    (-0.43%)
    793.00 USD
    MRK
    MRK
    0.100
    (0.10%)
    99.460 USD
    NVS
    NVS
    -0.110
    (-0.11%)
    98.310 USD
    PFE
    PFE
    0.000
    (0.00%)
    26.710 USD
    REGN
    REGN
    -0.89
    (-0.12%)
    714.09 USD
    المزيد
الأخبار
المقالات

العنوان: Titan Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.